Article info
Review
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
- Correspondence to Dr Pardeep S Jhund, British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK; pardeep.jhund{at}glasgow.ac.uk
Citation
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
Publication history
- Received October 5, 2015
- Accepted April 14, 2016
- First published May 20, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (19 October 2016).
- Previous version (26 November 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/